References
- 1. Margolis S, Dobs AS. Nutritional management of plasma lipid disorders. J Am Coll Nutr. 1989; 8 Suppl: 33S-45S.10.1080/07315724.1989.10737968
- 2. Perez-Jimenez F, Lopez-Miranda J, Mata P. Protective effect of dietary monounsaturated fat on arteriosclerosis: beyond cholesterol. Atherosclerosis. 2002; 163:385-98.10.1016/S0021-9150(02)00033-3
- 3. Dreon DM, Fernstrom HA, Miller B, Krauss RM. Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. Faseb J. 1994; 8:121-6.
- 4. Kasim-Karakas SE, Almario RU, Mueller WM, Peerson J. Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: effects of energy intake. The American journal of clinical nutrition. 2000; 71:1439-47.
- 5. Harland JO, Unwin N, Bhopal RS, White M, Watson B, Laker M, et al. Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population. J Epidemiol Community Health. 1997; 51: 636-42.10.1136/jech.51.6.636
- 6. Heng CK, Saha N, Low PS. Evolution of the apolipoprotein B gene and coronary artery disease: a study in low and high risk Asians. Ann Hum Genet. 1999; 63:45-62.10.1046/j.1469-1809.1999.6310045.x
- 7. Chen Z, Shu XO, Yang G, Li H, Li Q, Gao YT, et al. Nutrient intake among Chinese women living in Shanghai, China. Br J Nutr. 2006; 96:393-9.10.1079/BJN20061829
- 8. Saleheen D, Frossard P. CAD risk factors and acute myocardial infarction in Pakistan. Acta Cardiol. 2004; 59:417-24.10.2143/AC.59.4.2005208
- 9. Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. The American journal of clinical nutrition. 2000; 71:412-33.
- 10. Fried SK, Rao SP. Sugars, hypertriglyceridemia, and cardiovascular disease. The American journal of clinical nutrition. 2003; 78:873S-80S.
- 11. Codario RA. Hypertriglyceridemia and cardiovascular disease management. J Am Acad Nurse Pract. 2007; 19(12 Suppl 2):7-10, 3-4.
- 12. Fonseca N, Bernardino L, Silvestre I, Santos J, Seixo F, Mendes L, et al. Acute myocardial infarction in patients aged under 45 years. Rev Port Cardiol. 2004; 23:1585-91.
- 13. Glimcher LH, Lee AH. From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis. Ann N Y Acad Sci. 2009; 1173 Suppl 1: E2-9.
- 14. Salati LM, Szeszel-Fedorowicz W, Tao H, Gibson MA, Amir-Ahmady B, Stabile LP, et al. Nutritional regulation of mRNA processing. The Journal of nutrition. 2004; 134:2437S-43S.
- 15. Connelly PW, Hegele RA. Hepatic lipase deficiency. Crit Rev Cl Lab Sci. 1998; 35:547-72.10.1080/10408369891234273
- 16. Hill SA, McQueen J. Reverse cholesterol transport - A review of the process and its clinical implications. Clin Biochem. 1997; 30:517-25.10.1016/S0009-9120(97)00098-2
- 17. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol. 2003; 14:179-89.10.1097/00041433-200304000-00010
- 18. Zambon A, Deeb SS, Hokanson JE, Brown BG, Brunzell JD. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol. 1998; 18:1723-9.
- 19. Couture P, Otvos JD, Cupples LA, Lahoz C, Wilson PW, Schaefer EJ, et al. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 2000; 20:815-22.10.1161/01.ATV.20.3.815
- 20. Tahvanainen E, Syvanne M, Frick MH, Murtomaki- Repo S, Antikainen M, Kesaniemi YA, et al. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators. The Journal of clinical investigation. 1998; 101:956-60.
- 21. Wood KC, Fullerton MD, El-Sohemy A, Bakovic M. Interactions between hepatic lipase and apolipoprotein E gene polymorphisms affect serum lipid profiles of healthy Canadian adults. Appl Physiol Nutr Metab. 2008; 33:761-8.10.1139/H08-054
- 22. Jansen H, Verhoeven AJ, Weeks L, Kastelein JJ, Halley DJ, van den Ouweland A, et al. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol. 1997; 17:2837-42.10.1161/01.ATV.17.11.2837
- 23. Leclerc I, Davignon I, Lopez D, Garrel DR. No change in glucose tolerance and substrate oxidation after a high-carbohydrate, low-fat diet. Metabolism. 1993; 42: 365-70.10.1016/0026-0495(93)90088-6
- 24. Schwarz JM, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. American Journal of Clinical Nutrition. 2003; 77:43-50.
- 25. Guerra R, Wang J, Grundy SM, Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. P Natl Acad Sci USA. 1997; 94:4532-7.10.1073/pnas.94.9.4532
- 26. Satoh H, Nishino T, Tomita K, Tsutsui H. Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men. Circ J. 2006; 70:227-31.10.1253/circj.70.227
- 27. Lee MM, Wu-Williams A, Whittemore AS, Zheng S, Gallagher R, Teh CZ, et al. Comparison of dietary habits, physical activity and body size among Chinese in North America and China. Int J Epidemiol. 1994; 23:984-90.10.1093/ije/23.5.984
- 28. Masson LF, McNeill G, Avenell A. Genetic variation and the lipid response to dietary intervention: a systematic review. The American journal of clinical nutrition. 2003; 77:1098-111.
- 29. Masson LF, McNeill G. The effect of genetic variation on the lipid response to dietary change: recent findings. Curr Opin Lipidol. 2005; 16:61-7.10.1097/00041433-200502000-00011
- 30. Price TM, O’Brien SN, Welter BH, George R, Anandjiwala J, Kilgore M. Estrogen regulation of adipose tissue lipoprotein lipase-possible mechanism of body fat distribution. Am J Obstet Gynecol. 1998; 178:101-7.10.1016/S0002-9378(98)70634-9
- 31. Murtomaki S, Tahvanainen E, Antikainen M, Tiret L, Nicaud V, Jansen H, et al. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol. 1997; 17:1879-84.10.1161/01.ATV.17.10.1879
- 32. Brand K, Dugi KA, Brunzell JD, Nevin DN, Santamarina-Fojo S. A novel A?G mutation in intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. J Lipid Res. 1996; 37: 1213-23.